Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04448002 · ClinicalTrials.gov registry record · NA
AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
A NA study of Asthma, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 2
- Study locations
NCT04448002: Active NA study of Asthma, sponsored by University of Florida.
NCT04448002 is a NA study of Asthma that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 320 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04448002, a NA study of Asthma, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver
Primary Outcome
Measured via the Asthma Control Test questionnaire which has 5 items that assesses frequency of daytime and nocturnal asthma symptoms, activity limitations, and perceptions of disease control.Adolescents will complete all 5 items independently of caregivers. Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score \>19 indicates well-controlled asthma."
Conditions Studied
Interventions
- BEHAVIORAL AIM2ACT
- BEHAVIORAL mHealth Attention Control Condition
Study Locations (2)
Florida
- UF Health Pediatrics - Gainesville
- Nemours Children's Hospital - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04448002 still lists
NCT04448002 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which AIM2ACT is the first listed.
NCT04448002 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04448002 about?
NCT04448002 is a clinical study titled "AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma". The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver
What is the current status of trial NCT04448002?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2021-04-23. Estimated completion is 2026-03-31.
What conditions does trial NCT04448002 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT04448002?
The interventions under investigation include: AIM2ACT (BEHAVIORAL), mHealth Attention Control Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04448002?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04448002 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04448002's enrollment target sits among peer trials
320 117th of 374 higher than 258 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI